Medsider

We unpack the insights, tactics, and secrets behind the most successful medtech and healthtech startups in the world.

[Medsider @medsider]

2/2 As Teal founder Kara Egan explains, convenience alone isn’t enough in preventive care. Patients also need confidence, clarity, and support once the test result is available.

More in @scottnelsonlive’s interview with Kara: https://t.co/tMqCurEpap

[Medsider @medsider]

1/2 @TealHealth didn’t treat at-home cervical cancer screening as just a kit.

The company built telehealth, reminders, and clinician follow-up around the experience so patients felt supported from start to finish. 👇🏼

[Medsider @medsider]

2/2 Different buyers wanted different outcomes:
➡️ ER diversion
➡️ Closing access gaps
➡️ Recruitment and retention

More in @scottnelsonlive’s interview with Karthik: https://t.co/zXp9BQSsYN

[Medsider @medsider]

1/2 @onmedstation is obsessed with patient experience.

But Karthik Ganesh built the business around a different reality: healthcare dollars flow enterprise-down, not patient-up.

That changed how OnMed sold to employers, payers, universities, and government systems. 👇🏼

[Medsider @medsider]

2/2 That showed up in self-pay, outreach from prior scans, and new entry points beyond traditional workflows.

More in @scottnelsonlive’s interview: https://t.co/nexzqSREMy

[Medsider @medsider]

1/2 @ClairityAI built an AI platform that predicts a woman’s 5-year breast cancer risk from a routine mammogram.

CEO Connie Lehman focused early on one question: how do women actually access it? 👇🏼

[Medsider @medsider]

2/2 Check out @scottnelsonlive’s new interview with CEO Kurt Jacobus to learn more: https://t.co/rhWjBLoDVM

[Medsider @medsider]

1/2
520(b) gave @restor3d_ a way to enter the market early:

→ Treat patients
→ Generate revenue
→ Gain evidence

All before a 510(k).👇

[Medsider @medsider]

Check out @scottnelsonlive’s interview with #LightForceBraces CEO Alfred Griffin: https://t.co/WvemA6OvmS

[Medsider @medsider]

1/2 “Building it once is easy. Building it a million times is hard.”

LightForce didn’t win with a novel idea.

They won by building a system to scale mass customization.

Why this eventually became the real moat. 👇

[Medsider @medsider]

2/2 Nearly 80% of prescribing physicians first heard about Osteoboost from their patients.

Check out @scottnelsonlive’s new interview with Laura Yecies: https://t.co/UnAEJ8eL3u

[Medsider @medsider]

1/2 Most medtech companies sell to physicians first.

@osteoboost did the opposite.

CEO @lyecies turned early patient demand into a ‘Founders Program’ — and those patients became the company’s sales force.

How patient pull can drive physician adoption… 👇

[Medsider @medsider]

2/2 Consistent outcomes, reliability, and patient experience matter more than novelty in high-risk procedures.

Check out @scottnelsonlive’s new interview with Stephen here https://t.co/8MXOugI8En

[Medsider @medsider]

1/2 Innovation in medtech shouldn’t force physicians to relearn their procedure.

As Secure Closure CEO Stephen Belcher puts it: “We’re using a method physicians are already familiar with — but changing how the device works to improve reliability.”👇

[Medsider @medsider]

2/2 SonoVascular CEO Daniel Estay shares how he evaluates new opportunities — and why picking the right first indication can shape everything that follows.

Check out @scottnelsonlive’s new interview with Dan: https://t.co/ieOjAQSu4p

[Medsider @medsider]

1/2 Differentiated technology doesn’t guarantee a sustainable medtech company.
What actually determines whether a startup survives?

Not just whether the device works — but whether the market is big enough, investable, and aligned with your tech’s current capabilities. 👇

[Medsider @medsider]

2/2 Check out @scottnelsonlive’s full conversation with Matthias here: https://t.co/tk6g87vsqC

[Medsider @medsider]

1/2 Matthias Hofmann, CEO of @Eyebot, shared how they validated market pull.

They put a scrappy prototype in a mall with a “Free vision test” sign.

Result: 60–100 people showed up daily.
Real-world traction is the strongest signal for potential investors. 👇

[Medsider @medsider]

Check out @scottnelsonlive’s new interview with Max: https://t.co/yubKMUVLKs

[Medsider @medsider]

1/2 A leadership lesson from @CMRSurgical CEO Max Colella:

Startup speed is only achieved when you can actively remove the bureaucracy inherited from big-company playbooks.

Why stripping processes can be just as important as building a strategy. 👇🏼